Worldwide Life Science Analytics Industry to 2029 – Increasing Acceptance of Analytics Solutions in Clinical Trials is Driving Growth – ResearchAndMarkets.com

Worldwide Life Science Analytics Industry to 2029 - Increasing Acceptance of Analytics Solutions in Clinical Trials is Driving Growth - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Life Science Analytics Market Analysis by Component, by Type, by Application, by Delivery, by End User by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The life science analytics market size is estimated to be USD 24.6 billion in 2021 and is expected to witness a CAGR of 15.31% during the forecast period 2022-2029.

Technological advancements, data storage in the life sciences industry, increasing acceptance of analytics solutions in clinical trials, rising adoption of analytics for sales and marketing applications, and demand for improved data standardisation are some of the major factors that boosts global market growth.

Also, rising incidence of chronic diseases, mounting pressure to reduce healthcare spending, and the need for improved patient outcomes are other factors that propelling the growth during the forecast period. However, high implementation cost hindering the market growth.

Companies Mentioned

Oracle Corporation (US)

Accenture (Ireland)

SAS Institute Inc. (US)

IBM Corporation (US)

IQVIA (US)

Wipro (India)

Cognizant (US)

SCIO Health Analytics (US)

Allscripts Healthcare Solutions (US)

Cerner Corporation (US)

Microsoft (US)

Infosys Limited (US)

MaxisIT (US)

Optum (US)

Cotiviti (US)

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including component, type, application, delivery, and end user from 2021 to 2029.

Segmentation: Life Science Analytics Market Report 2021-2029

By Component (Revenue, USD Billion)

Software

Services

By Type (Revenue, USD Billion)

Descriptive

Reporting

Prescriptive

Predictive

By Application (Revenue, USD Billion)

Sales & Marketing Support

Research & Development

Supply Chain Analytics

Pharmacovigilance

Regulatory Compliance

By Delivery (Revenue, USD Billion)

On-premises

On-demand

By End User (Revenue, USD Billion)

Biotechnology

Medical Device

Pharmaceutical

Others

By Region (Revenue, USD Billion)

North America

U.S

Canada

Europe

Germany

France

UK

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East & Africa

South Africa

GCC

Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/85btx1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.